Affiliations 

  • 1 National Drug and Alcohol Research Centre, University of New South Wales, Sydney, New South Wales, Australia; School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia. Electronic address: L.Degenhardt@unsw.edu.au
  • 2 Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia
  • 3 Center for Public Health and Human Rights, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States
  • 4 International Harm Reduction Development Program, Open Society Foundations, New York, NY, United States
  • 5 Centre of Excellence for Research in AIDS (CERiA), Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
  • 6 INSERM, U912 (SESSTIM), Marseille, France; Université Aix Marseille, IRD, UMR-S912, Marseille, France; ORS PACA, Observatoire Régional de la Santé Provence Alpes Côte d'Azur, Marseille, France
  • 7 University of California, San Diego, Division of Global Public Health, Department of Medicine, United States
  • 8 Global Drug Policy Program, Open Society Foundations, Warsaw, Poland
  • 9 UN Secretary-General special Envoy on HIV/AIDS in Eastern Europe and Central Asia, Geneva, Switzerland
Int J Drug Policy, 2014 Jan;25(1):53-60.
PMID: 24113623 DOI: 10.1016/j.drugpo.2013.08.004

Abstract

In 2010 the international HIV/AIDS community called on countries to take action to prevent HIV transmission among people who inject drugs (PWID). To set a baseline we proposed an "accountability matrix", focusing upon six countries accounting for half of the global population of PWID: China, Malaysia, Russia, Ukraine, Vietnam and the USA. Two years on, we review progress.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.